About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Performance and Safety of T2769 in DED | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT05965778

Performance and Safety of T2769 in DED

To demonstrate the non-inferiority of T2769 compared to Vismed® Multi in terms of total ocular surface staining (Oxford score) after 35 days of treatment. To evaluate the performance and safety of T2...

Lead sponsor: Laboratoires Thea•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Laboratoires Thea

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Informed consent signed and dated (obtained prior to initiating any procedures).
•Patient aged ≥18 years old.
•Known dry eye syndrome requiring artificial tears for at least the last 3 months prior to screening visit.
•Surface Disease Index (OSDI) Score ≥ 23.
•Ocular discomfort evaluated by VAS ≥ 40 mm.

Exclusion Criteria

•Far best-corrected visual acuity (BCVA) ≥+0.7 LogMar (e.g., ≤0.2 in decimal value or ≤20/100 Snellen equivalent or ≤50 (ETDRS) letters Early Treatment Diabetic Retinopathy Study).
•Severe blepharitis according to the judgment of the investigator
•Dry eye associated with at least one of the following diseases/symptoms: ocular rosacea, Pterygium, Eyelid malposition, Corneal dystrophy, Ocular neoplasia, Filamentous keratitis, Corneal neovascularisation, Orbital radiotherapy, Cataract, Retinal disease.

Related studies

RECRUITINGPhase 4

A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study

NCT07463950 · Dry Eye Disease (DED)

A Study on the Correlation Between Tear Iron Levels and the Severity of Dry Eye Disease.

NCT07363824 · Dry Eye Disease, Iron

RECRUITINGPhase 4

Supplementary Kelulut Honey Therapy in Juvenile Open-Angle Glaucoma: Effects on IL-6, RNFL and Dry Eye

NCT07396441 · Juvenile Open Angle Glaucoma, Dry Eye Disease (DED), and more

Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease

NCT05865457 · Dry Eye Disease

Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease

NCT05865379 · Dry Eye Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 23, 2026Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment251

Start dateOct 2023

Last updatedJan 23, 2026

Condition

Locations shown

Gabriel-Montpied University Hospital

Clermont-Ferrand

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 23, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions